These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 12499259

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):165-70. PubMed ID: 12006990
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H, Mansel RE, Jiang WG.
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [Abstract] [Full Text] [Related]

  • 5. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M.
    Cancer Res; 2005 Jul 01; 65(13):5864-71. PubMed ID: 15994964
    [Abstract] [Full Text] [Related]

  • 6. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Jul 01; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 7. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.
    Palmieri D, Astigiano S, Barbieri O, Ferrari N, Marchisio S, Ulivi V, Volta C, Manduca P.
    Exp Cell Res; 2008 Jul 01; 314(11-12):2289-98. PubMed ID: 18570923
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.
    Exp Clin Endocrinol Diabetes; 2002 Nov 01; 110(8):386-92. PubMed ID: 12518248
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA.
    Cancer Res; 2009 Jan 01; 69(1):349-57. PubMed ID: 19118020
    [Abstract] [Full Text] [Related]

  • 10. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W.
    Cancer Res; 2005 Jan 15; 65(2):465-72. PubMed ID: 15695388
    [Abstract] [Full Text] [Related]

  • 11. Roles of angiogenic factors and endothelin-1 in gastric ulcer healing.
    Akimoto M, Hashimoto H, Maeda A, Shigemoto M, Yamashita K.
    Clin Sci (Lond); 2002 Aug 15; 103 Suppl 48():450S-454S. PubMed ID: 12193143
    [Abstract] [Full Text] [Related]

  • 12. SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.
    Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M.
    Cancer Lett; 2006 May 08; 236(1):39-45. PubMed ID: 15967572
    [Abstract] [Full Text] [Related]

  • 13. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 14. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression.
    Serratì S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I, Liotta F, Annunziato F, Pucci M, Del Rosso M.
    J Pathol; 2008 Apr 17; 214(5):545-54. PubMed ID: 18189329
    [Abstract] [Full Text] [Related]

  • 15. Role of CXCL12 in metastasis of human ovarian cancer.
    Jiang YP, Wu XH, Xing HY, DU XY.
    Chin Med J (Engl); 2007 Jul 20; 120(14):1251-5. PubMed ID: 17697577
    [Abstract] [Full Text] [Related]

  • 16. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD, Cher ML.
    Prostate; 2006 Jan 01; 66(1):32-48. PubMed ID: 16114056
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T.
    Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
    Wey JS, Fan F, Gray MJ, Bauer TW, McCarty MF, Somcio R, Liu W, Evans DB, Wu Y, Hicklin DJ, Ellis LM.
    Cancer; 2005 Jul 15; 104(2):427-38. PubMed ID: 15952180
    [Abstract] [Full Text] [Related]

  • 19. PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
    Smadja DM, Bièche I, Uzan G, Bompais H, Muller L, Boisson-Vidal C, Vidaud M, Aiach M, Gaussem P.
    Arterioscler Thromb Vasc Biol; 2005 Nov 15; 25(11):2321-7. PubMed ID: 16141404
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S.
    Clin Cancer Res; 2006 May 01; 12(9):2795-803. PubMed ID: 16675573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.